Vivos Other Assets vs Long Term Debt Analysis

VVOS Stock  USD 4.55  0.06  1.30%   
Vivos Therapeutics financial indicator trend analysis is much more than just breaking down Vivos Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Vivos Therapeutics is a good investment. Please check the relationship between Vivos Therapeutics Other Assets and its Long Term Debt accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vivos Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Vivos Stock please use our How to Invest in Vivos Therapeutics guide.

Other Assets vs Long Term Debt

Other Assets vs Long Term Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Vivos Therapeutics Other Assets account and Long Term Debt. At this time, the significance of the direction appears to have pay attention.
The correlation between Vivos Therapeutics' Other Assets and Long Term Debt is -0.79. Overlapping area represents the amount of variation of Other Assets that can explain the historical movement of Long Term Debt in the same time period over historical financial statements of Vivos Therapeutics, assuming nothing else is changed. The correlation between historical values of Vivos Therapeutics' Other Assets and Long Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Assets of Vivos Therapeutics are associated (or correlated) with its Long Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Debt has no effect on the direction of Other Assets i.e., Vivos Therapeutics' Other Assets and Long Term Debt go up and down completely randomly.

Correlation Coefficient

-0.79
Relationship DirectionNegative 
Relationship StrengthWeak

Other Assets

Long Term Debt

Long-term debt is a debt that Vivos Therapeutics has held for over one year. Long-term debt appears on Vivos Therapeutics balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Vivos Therapeutics balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.
Most indicators from Vivos Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Vivos Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vivos Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Vivos Stock please use our How to Invest in Vivos Therapeutics guide.At this time, Vivos Therapeutics' Issuance Of Capital Stock is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 1.85 in 2024, whereas Selling General Administrative is likely to drop slightly above 21.8 M in 2024.
 2021 2022 2023 2024 (projected)
Interest Expense14K1.2M1.4M1.4M
Depreciation And Amortization733K669K621K549.9K

Vivos Therapeutics fundamental ratios Correlations

0.240.840.610.830.580.680.270.61-0.92-0.480.270.94-0.030.470.49-0.590.940.72-0.60.670.49-0.320.880.650.51
0.240.520.88-0.210.560.40.480.860.03-0.60.710.10.290.750.77-0.80.10.09-0.820.470.710.390.470.530.9
0.840.520.860.50.740.810.490.83-0.68-0.740.670.740.170.710.75-0.880.740.47-0.880.90.810.10.870.830.82
0.610.880.860.160.710.660.520.98-0.37-0.740.760.480.220.860.9-0.950.480.34-0.970.760.840.250.760.740.98
0.83-0.210.50.160.150.3-0.030.17-0.97-0.02-0.160.94-0.290.140.08-0.090.940.84-0.090.360.05-0.60.60.30.04
0.580.560.740.710.150.960.890.69-0.27-0.980.850.340.740.290.4-0.870.34-0.06-0.810.850.910.530.760.950.77
0.680.40.810.660.30.960.830.66-0.41-0.950.770.460.660.290.39-0.820.460.02-0.780.90.870.430.830.960.7
0.270.480.490.52-0.030.890.830.52-0.03-0.90.870.090.930.080.14-0.680.09-0.28-0.60.790.850.770.590.890.63
0.610.860.830.980.170.690.660.52-0.37-0.730.710.480.230.870.89-0.920.480.34-0.950.740.80.20.820.730.95
-0.920.03-0.68-0.37-0.97-0.27-0.41-0.03-0.370.170.0-0.990.28-0.35-0.310.3-0.99-0.870.3-0.5-0.220.52-0.71-0.42-0.25
-0.48-0.6-0.74-0.74-0.02-0.98-0.95-0.9-0.730.17-0.91-0.24-0.76-0.36-0.460.9-0.240.150.85-0.87-0.95-0.63-0.73-0.94-0.81
0.270.710.670.76-0.160.850.770.870.710.0-0.910.090.720.430.51-0.880.09-0.19-0.830.840.970.790.540.860.86
0.940.10.740.480.940.340.460.090.48-0.99-0.240.09-0.240.450.41-0.391.00.88-0.410.560.31-0.470.760.490.36
-0.030.290.170.22-0.290.740.660.930.230.28-0.760.72-0.24-0.23-0.14-0.44-0.24-0.59-0.350.530.650.850.290.680.37
0.470.750.710.860.140.290.290.080.87-0.35-0.360.430.45-0.230.98-0.710.450.5-0.780.480.51-0.060.560.370.79
0.490.770.750.90.080.40.390.140.89-0.31-0.460.510.41-0.140.98-0.790.410.4-0.850.520.580.010.580.430.84
-0.59-0.8-0.88-0.95-0.09-0.87-0.82-0.68-0.920.30.9-0.88-0.39-0.44-0.71-0.79-0.39-0.130.99-0.85-0.94-0.43-0.76-0.86-0.97
0.940.10.740.480.940.340.460.090.48-0.99-0.240.091.0-0.240.450.41-0.390.88-0.410.560.31-0.470.760.490.36
0.720.090.470.340.84-0.060.02-0.280.34-0.870.15-0.190.88-0.590.50.4-0.130.88-0.180.21-0.01-0.70.480.10.19
-0.6-0.82-0.88-0.97-0.09-0.81-0.78-0.6-0.950.30.85-0.83-0.41-0.35-0.78-0.850.99-0.41-0.18-0.8-0.9-0.35-0.76-0.8-0.98
0.670.470.90.760.360.850.90.790.74-0.5-0.870.840.560.530.480.52-0.850.560.21-0.80.920.440.830.960.79
0.490.710.810.840.050.910.870.850.8-0.22-0.950.970.310.650.510.58-0.940.31-0.01-0.90.920.640.70.940.91
-0.320.390.10.25-0.60.530.430.770.20.52-0.630.79-0.470.85-0.060.01-0.43-0.47-0.7-0.350.440.640.010.50.42
0.880.470.870.760.60.760.830.590.82-0.71-0.730.540.760.290.560.58-0.760.760.48-0.760.830.70.010.840.71
0.650.530.830.740.30.950.960.890.73-0.42-0.940.860.490.680.370.43-0.860.490.1-0.80.960.940.50.840.79
0.510.90.820.980.040.770.70.630.95-0.25-0.810.860.360.370.790.84-0.970.360.19-0.980.790.910.420.710.79
Click cells to compare fundamentals

Vivos Therapeutics Account Relationship Matchups

Vivos Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets7.6M25.3M33.7M13.7M10.7M18.2M
Short Long Term Debt Total3.7M1.3M1.6M2.4M2.0M2.1M
Other Current Liab1.4M3.2M2.9M1.6M2.5M2.2M
Total Current Liabilities9.1M7.8M7.5M6.8M7.3M7.5M
Total Stockholder Equity(2.9M)16.9M25.5M4.8M411K390.5K
Property Plant And Equipment Net1.1M871.6K2.8M4.8M4.7M2.9M
Current Deferred Revenue2.9M2.9M2.4M2.9M2.1M2.6M
Net Debt3.2M(16.9M)(22.4M)(1.1M)352K369.6K
Retained Earnings(23.3M)(35.3M)(55.6M)(79.5M)(93.1M)(88.4M)
Accounts Payable1.1M781K920K1.4M2.1M1.2M
Cash469.4K18.2M24.0M3.5M1.6M1.6M
Non Current Assets Total5.6M4.9M6.4M8.3M8.3M7.3M
Non Currrent Assets Other1.1M1.1M356K374K307K433.5K
Cash And Short Term Investments469.4K18.2M24.0M3.5M1.6M1.6M
Net Receivables956.0K1.5M1.7M457K202K191.9K
Common Stock Shares Outstanding727.7K728.4K849.3K920.5K1.2M899.6K
Liabilities And Stockholders Equity7.6M25.3M33.7M13.7M10.7M18.2M
Non Current Liabilities Total1.4M587.1K641K2.1M3.0M1.6M
Other Current Assets295.0K1.3M1.6M1.4M616K997.7K
Other Stockholder Equity20.3M50.8M81.2M84.3M93.5M63.7M
Total Liab10.5M8.4M8.2M8.9M10.3M9.1M
Net Invested Capital766.5K18.2M26.8M4.8M411K390.5K
Property Plant And Equipment Gross1.1M871.6K4.1M6.5M7.0M3.8M
Total Current Assets2.0M20.4M27.3M5.4M2.5M2.3M
Net Working Capital(7.1M)12.6M19.8M(1.4M)(4.8M)(4.6M)
Short Term Debt3.7M867.0K1.3M838K474K450.3K
Intangible Assets689.2K270.1K341K302K420K421.7K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Vivos Stock Analysis

When running Vivos Therapeutics' price analysis, check to measure Vivos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivos Therapeutics is operating at the current time. Most of Vivos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vivos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivos Therapeutics' price. Additionally, you may evaluate how the addition of Vivos Therapeutics to your portfolios can decrease your overall portfolio volatility.